An improved folic acid absorption test is described in detail. Using the folic acid and other absorption tests, a study of intestinal function has been made in eight patients with lymphosarcoma, eight with chronic lymphocytic leukaemia, two with Hodgkin's disease, and one each with reticulum cell sarcoma, Whipple's disease, and macroglobulinaemia. It was found that laboratory evidence of intest...

Intestinal calcium (Ca) absorption was measured under noninvasive conditions in both normally cycling and ovariectomized rats by determining the decrease in 47Ca/47Sc ratio between diet and feces. In 32-wk-old rats fed a 1.4% Ca diet, both fractional and total intestinal Ca absorption varied during the estrous cycle (p < 0.03), being highest during estrus and lowest during the second day of die...

In a preceding report of ours1 we demonstrated an impaired intestinal absorp tion of 57CoB12 in vitamin B2 deficient rats and that this impairment of 57CoB12 absorption might be due to a deficiency of intrinsic factor caused by vitamin B2 deficiency. In 1963 Hsu2 made a detailed investigation upon intestinal absorption of 60CoB12 in rats with deficiency of other vitamins than vitamin B12 and co...

P-glycoprotein (P-gp) and CYP3A (cytochrome P450 3A, generally; Cyp3a, rodent enzyme) in the intestine can attenuate absorption of orally administered drugs. While some suggest that P-gp enhances intestinal metabolism by CYP3A/Cyp3a during absorption of a dual substrate, others suggest that P-gp reduces the metabolism in the intestine when substrates are at subsaturating concentrations. Hence, ...

P-glycoprotein (P-gp) and CYP3A (cytochrome P450 3A, generally; Cyp3a, rodent enzyme) in the intestine can attenuate absorption of orally administered drugs. While some suggest that P-gp enhances intestinal metabolism by CYP3A/Cyp3a during absorption of a dual substrate, others suggest that P-gp reduces the metabolism in the intestine when substrates are at subsaturating concentrations. Hence, ...

The effect of Wellsolve, a new solubilizing agent, on the function of intestinal membrane barrier and transporters including P-glycoprotein (P-gp) and peptide transporter (PEPT1) was examined by an in vitro diffusion chamber and an in situ closed loop method. The model drugs used in this study were 5(6)-carboxyfluorescein (CF), rhodamine123 (a P-glycoprotein substrate), cephalexin (a typical su...

This study aimed to construct a new local pharmacokinetic model of gastrointestinal absorption, the translocation model (TLM), using an anatomically relevant, minimally segmented structure to explain linear and nonlinear intestinal absorption, metabolism, and transport. The TLM was based on the concept of a single absorption site that flexibly moves, expands, and shrinks along with the length o...

LAL, DHEERAJ, AND HAROLD P. SCHEDL. Intestinal adaptation in diabetes: amino acid absorption. Am. J. Physiol. 227(4): 827-831. 1974.-Since the diabetic rat shows adaptations in intestinal hexose absorption, we studied amino acid absorption 5 and 12 days after induction of diabetes with alloxan or streptozotocin. We perfused the entire small intestine intraluminally with 5 mM amino acid solution...